 |
|
Targeted nanoparticles incorporating siRNA offer promise for cancer treatment
May 21, 2007Study from Caltech
The use of targeted nanoparticles offers promising techniques for cancer treatment. Researchers in the laboratory of Mark E. Davis at the California Institute of Technology have been using small interfering RNA (siRNA), sometimes known as silencing RNA, to "silence" specific genes that are implicated in certain malignancies. One of the primary challenges associated with this type of therapy is delivering the therapeutic agent into the body and then to the tumor in a safe and effective manner. By using targeted nanoparticles, researchers have demonstrated that systemically delivered siRNA can slow the growth of tumors in mice without eliciting the toxicities often associated with cancer therapies. The results of this research are being presented this week at the NSTI Nanotech 2007 Conference in Santa Clara, CA.
The Caltech researchers have incorporated siRNA into nanoparticles that are formed completely by self-assembly, characterized the behavior of these nanoparticles and studied their safety and efficacy in mice.
Using extensive physicochemical and biological characterization, the investigators are able to estimate the composition of individual nanoparticles and to correlate the nanoparticle structure with its biological function. This quantitative approach provides unique insights into the design of more effective nanoparticle carriers.
According to the lead author of the study, Derek W. Bartlett, "Safe and effective delivery remains perhaps the greatest impediment to the clinical realization of small interfering RNA (siRNA) in cancer therapy. Formation of siRNA nanoparticles using cyclodextrin-containing polycations is one of the most promising strategies for systemic siRNA delivery, and such nanoparticles are expected to enter Phase I clinical trials by late 2007. Our most recent work examines the impact of various dosing schedules and surface modifications on the efficacy of these siRNA nanoparticles in preclinical cancer models. By combining the experimental data with a mathematical model of siRNA-mediated gene silencing, we illustrate several practical considerations that we believe will be directly relevant to the clinical application of siRNA-based therapeutics in cancer therapy."
Elsevier Health Sciences
Using extensive physicochemical and biological characterization, the investigators are able to estimate the composition of individual nanoparticles and to correlate the nanoparticle structure with its biological function. This quantitative approach provides unique insights into the design of more effective nanoparticle carriers.
According to the lead author of the study, Derek W. Bartlett, "Safe and effective delivery remains perhaps the greatest impediment to the clinical realization of small interfering RNA (siRNA) in cancer therapy. Formation of siRNA nanoparticles using cyclodextrin-containing polycations is one of the most promising strategies for systemic siRNA delivery, and such nanoparticles are expected to enter Phase I clinical trials by late 2007. Our most recent work examines the impact of various dosing schedules and surface modifications on the efficacy of these siRNA nanoparticles in preclinical cancer models. By combining the experimental data with a mathematical model of siRNA-mediated gene silencing, we illustrate several practical considerations that we believe will be directly relevant to the clinical application of siRNA-based therapeutics in cancer therapy."
Elsevier Health Sciences
Cancer Treatment Current Events and Cancer Treatment News RSSFertility procedures need not delay breast cancer treatment for younger women
A new study published in the November issue of the Journal of the American College of Surgeons shows that breast cancer patients under 40 years old who undergo fertility preservation do not face a significant delay in the treatment of their disease when their care is coordinated in a timely fashion.
Discovery in worms by Queen's researchers points to more targeted cancer treatment
Researchers at Queen's University have found a link between two genes involved in cancer formation in humans, by examining the genes in worms. The groundbreaking discovery provides a foundation for how tumor-forming genes interact, and may offer a drug target for cancer treatment.
New mechanism explains how the body prevents formation of blood vessels
Researchers at Uppsala University, in collaboration with colleagues in Sweden and abroad, have identified an entirely new mechanism by which a specific protein in the body inhibits formation of new blood vessels.
For young boys with cancer, testicular tissue banking may be option to preserve fertility
For parents of children with cancer, the hopeful news is that pediatric survival rates have steadily improved for decades. Among the bad news-treatments that enable survival often cause infertility.
U.S. and European Experts Applaud Creation of New Transatlantic Task Force on Global Antibiotic Resistance Threat
Experts on both sides of the Atlantic applaud President Barack Obama and Swedish Prime Minister Fredrik Reinfeldt, representing the European Union (EU) Presidency, for establishing a transatlantic task force to address antibiotic resistance, an urgent and growing problem that threatens patient safety and public health worldwide.
Findings show nanomedicine promising for treating spinal cord injuries
Researchers at Purdue University have discovered a new approach for repairing damaged nerve fibers in spinal cord injuries using nano-spheres that could be injected into the blood shortly after an accident.
Stereotactic radiotherapy offers noninvasive, effective treatment for frail patients with early-stage lung cancer
Stereotactic body radiation therapy (SBRT) should be considered a new standard of care for early-stage lung cancer treatment in patients with co-existing medical problems, according to results from a national clinical trial led by UT Southwestern Medical Center physicians.
Discovery offers potential new pancreatic cancer treatment
Tiny particles that can carry drugs and target cancer cells may offer treatment hope for those suffering with pancreatic cancer. New research to be presented in November at the American Association of Pharmaceutical Scientists (AAPS) Annual Meeting in Los Angeles reveals that tumor-penetrating microparticles (TPM) have been specifically designed to break through hard-to-infiltrate barriers and deliver drugs more effectively and efficiently than the standard form of chemotherapy such as those injected through a vein.
Canadian cardiology team clears the way for lifesaving breast cancer treatment
A team of Canadian cardiologists, in collaboration with oncologists, are playing an important role in the war against breast cancer Dr. Michael McDonald told the Canadian Cardiovascular Congress 2009, co-hosted by the Heart and Stroke Foundation and the Canadian Cardiovascular Society.
Sensor biochips could aid in cancer diagnosis and treatment
It is very difficult to predict whether a cancer drug will help an individual patient: only around one third of drugs will work directly in a given patient.
More Cancer Treatment Current Events and Cancer Treatment News Articles
 |
Life Over Cancer: The Block Center Program for Integrative Cancer Treatment by Keith Block (Author), Andrew Weil M.D. (Foreword) Dr. Keith Block is at the global vanguard of innovative cancer care. As medical director of the Block Center for Integrative Cancer Treatment in Evanston, Illinois, he has treated thousands of patients who have lived long, full lives beyond their original prognoses. Now he has distilled almost thirty years of experience into the first book that gives patients a systematic, research-based plan for developing the physical and emotional vitality they need to meet the demands of treatment and recovery. Based on a profound understanding of how body and mind can work together to defeat disease, this groundbreaking book offers: • Innovative approaches to conventional treatments, such as “chronotherapy”–chemotherapy timed to patients’ unique circadian rhythms for... |
 |
Healing Cancer Directed By: Mike Anderson HEALING CANCER (DVD MOVIE) |
|
Alternative Cancer Treatment by Peter Mann natural remedies for cancer Everything you ever wanted to know about alternative cancer treatment is contained in this unique guide...Kindle blogs are fully downloaded onto your Kindle so you can read them even when you're not wirelessly connected. And unlike RSS readers which often only provide headlines, blogs on Kindle give you full text content and images, and are updated wirelessly throughout the day. | |
 |
Relaxation, Imagery and Meditation: Healing Practices to Complement Cancer Treatment by Carolyn McManus |
 |
My Pink Ribbon Book A Breast Cancer Treatment Journal and Organizer for BODY. MIND. SPIRIT by Vera Bradley This journal was lovingly created to be a companion for your journey. Not only a useful tool, it's a helpmate and confidante, and can assist you in making sense of everything as you chart your own course toward recovery. Also makes a thoughful gift for that special person! Measures 8" X 9" |
|
Options in the Treatment of Breast Cancer [VHS] Starring: B. Elliot Grysen M.D. J.D. Directed By: B. Elliot Grysen M.D. J.D. Also With: B. Elliot Grysen M.D. J.D. (Primary Contributor) This video production is based on the counseling sessions used by Dr. Mark Campbell to explain to his patients what breast cancer treatment options are available. These sessions have been widely acclaimed by patients and cancer support groups and now have been recorded and edited to present the same information to other patients and their families. | |
 |
Hypnosis Support for Cancer Treatment Gwen Randall-Young (Primary Contributor) |
 |
Graviola Pure Extract x100 - Cancer Cure, Graviola, Cure For Cancer, Alternative Cancer Treatment; Natural Cancer Treatment by AB Marketers LLC Product OverviewGraviola Pure Extract x100 capsNowadays cancer is one of the most feared disease due to there is no cure for it yet. Although there is a natural and effective way to prevent different types of carcinogenic cells (cancer cells) to reproduce in your body.Laboratories of the University of Purdue in the state of Indiana - USA affirm that the Graviola (a fruit high in carbohydrates vitamin C vitamin B1 and vitamin B2) contains high anti-carcinogenic and cytotoxic components for different types of carcinogenic cells.Keeping this in mind The Graviola Pure Extracts caps were made to eliminate different kind of carcinogenic cells. These natural anti-cancer pills come in 100 capsules presentation to take two or three times daily. Due to its high content of anti-carcinogenic you... |
 |
The Cancer Treatment Revolution: How Smart Drugs and Other New Therapies are Renewing Our Hope and Changing the Face of Medicine by David G. Nathan M.D. (Author) Praise for The Cancer Treatment Revolution "A wonderful journey through modern medical science, told with warmth and insight, brought to life through the stories of people confronting cancer. This book will inspire and educate both laymen and caregivers." "This is probably the best book on cancer that exists--beautifully written and unfailingly interesting, conveying a clear sense of hope for cancer patients and survivors. Cancer treatment has come a long way but not without intense struggles and passions, which David Nathan narrates from the inside as one of the leading players. He explains cancer more clearly than anyone else, and... |
 |
FlameEz-Colon, 60 Capsules/Bottle by FlameEz Inflammatory bowel disease (IBD) is caused by chronic inflammation in digestive tract which leads to severe abdominal pain and diarrhea. Crohn's disease and ulcerative colitis are the most common forms of IBD. Chronic inflammation also plays a significant role in colon cancer. Inflammation promotes oxidative damage, DNA mutation, and cell transformation. Inflammatory mediators act as a tumor promoter, stimulate the proliferation of both untransformed and tumor cells. Tumor cells also amplify inflammatory responses by attracting more inflammatory cells to infiltrate the tumor. Such vicious cycle leads to tissue disruption and metastasis. The importance of inflammation in cancer progression has already led to clinical trials of anti-inflammatory cancer therapy. It is believed that... |
| © 2009 BrightSurf.com |